GDF-15 (a biomarker for metformin) and the risk of COVID-19: A two-sample Mendelian randomization study

BACKGROUND: Regarding the impact of metformin on COVID-19, there are currently varying opinions from multiple studies. Growth differentiation factor 15 (GDF-15) is a biomarker of metformin use and dosage, and we used two-sample Mendelian randomization (MR) to assess the causal effect of GDF-15 (metf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ya, Yao, Peishan, Li, Kai, Qin, Shanyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545159/
https://www.ncbi.nlm.nih.gov/pubmed/37773870
http://dx.doi.org/10.1097/MD.0000000000034675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545159/
https://www.ncbi.nlm.nih.gov/pubmed/37773870
http://dx.doi.org/10.1097/MD.0000000000034675

Ejemplares similares